Vinorelbine in Treating Patients With Metastatic Prostate Cancer
NCT00003259
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
vinorelbine tartrate
Sponsor
Swiss Cancer Institute